Related Experiment Video

Updated: Aug 6, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease

P Teismann1, M Schwaninger, F Weih

  • 1Institute of Pharmacology and Toxicology, Faculty of Pharmacy, Philipps-University of Marburg, Germany.

Neuroreport
|April 17, 2001
PubMed

Insights

This study investigated hydroxyl free radicals and nuclear factor-kappaB (NF-kappaB) in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Parkinson

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Parkinson's disease is a neurodegenerative disorder.
  • The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model is widely used to study Parkinson's disease.
  • Oxidative stress and inflammation are implicated in Parkinson's disease pathogenesis.

Purpose of the Study:

  • To investigate the role of hydroxyl free radicals in the MPTP model of Parkinson's disease.
  • To determine the involvement of nuclear factor-kappaB (NF-kappaB) activation in MPTP-induced neurotoxicity.
  • To assess the impact of NF-kappaB deficiency on neurochemical and immunocytochemical changes in the MPTP model.

Main Methods:

  • MPTP administration to C57BL/6 mice.
  • Measurement of hydroxyl free radicals using microdialysis and the salicylate hydroxylation assay.
  • Electrophoretic mobility shift assays to detect NF-kappaB activation.
  • Comparison of MPTP effects in p50-deficient mice and wildtype mice.

Main Results:

  • MPTP significantly increased hydroxyl free radical levels in the striatum.
  • NF-kappaB activation was not detected after MPTP treatment.
  • p50-deficient mice exhibited minimal alterations in striatal dopamine, metabolites, and tyrosine hydroxylase immunoreactivity post-MPTP exposure compared to controls.

Conclusions:

  • Hydroxyl free radical production is enhanced in the MPTP model.
  • NF-kappaB appears to play a minor role in the neurochemical and immunocytochemical changes observed in this MPTP model.
  • These findings suggest that targeting NF-kappaB may not be a primary therapeutic strategy for MPTP-induced Parkinsonism.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...